The company has decent tech, over $4m plus in the bank, new...

The company has decent tech, over $4m plus in the bank, new management, phase 3 clinical testing this year for tg4010 funded by Transgene, Transgene also expect to secure a new partner for TG4010 before the end of this year, VHL are looking to expand their tech portfolio and just secured new technology as we're all aware of.

As the saying goes, do your own research. If you want out then sell, I'm not buying more but I'm happy to hold.

I also think the last thing holders on this forum want is to be essentially referred to as f*wits, vent at the company if you really need to, but leave the rest of out of that rubbish.

All the best to holders.